Terbinafine Hydrochloride

Manufacturer: Walgreen Company
Effective date: 2017-07-17
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 22:51:58

Label at a glance#

ProductTerbinafine Hydrochloride

Active ingredientTerbinafine Hydrochloride

Label structure11 sections

Indications and uses

cures most jock itch (tinea cruris) relieves itching, burning, cracking and scaling which accompanies this condition

Dosage and administration

adults and children 12 years and older use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying for jock itch apply once a day (morning or night) for 1 week or as directed by a doctor. wash hands after each use children under 12 years: ask a doctor

Storage and handling

do not use if seal on tube is broken or is not visible store at controlled room temperature 20°-25°C (68°-77°F) see carton or tube crimp for lot number and expiration date

Contacts and useful links#

PhoneFDA MedWatch1-800-FDA-1088

PhoneLabel contact1-866-923-4914

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Terbinafine hydrochloride 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

cures most jock itch (tinea cruris)
relieves itching, burning, cracking and scaling which accompanies this condition

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

on nails or scalp
in or near the mouth or the eyes
for vaginal yeast infections

OTC - WHEN USING SECTION

When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

too much irritation occurs or gets worse.
side effects occur. You may report side effects to FDA at 1-800-FDA-1088.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years and older
- use the tip of the cap to break the seal and open the tube
- wash the affected skin with soap and water and dry completely before applying
- for jock itch apply once a day (morning or night) for 1 week or as directed by a doctor.
- wash hands after each use
children under 12 years: ask a doctor

Other information

STORAGE AND HANDLING SECTION

do not use if seal on tube is broken or is not visible
store at controlled room temperature 20°-25°C (68°-77°F)
see carton or tube crimp for lot number and expiration date

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

Questions?

OTC - QUESTIONS SECTION

Call 1-866-923-4914

SPL UNCLASSIFIED SECTION

DISTRIBUTED BY: WALGREEN CO.
200 WILMOT RD., DEERFIELD, IL 60015

PRINCIPAL DISPLAY PANEL - 15 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Walgreens

Jock Itch Cream

TERBINAFINE HYDROCHLORIDE
CREAM 1% / ANTIFUNGAL

NET WT 0.5 OZ (15 g)

PRINCIPAL DISPLAY PANEL - 15 g Tube Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
992528	terbinafine HCl 1 % Topical Cream	PSN	2
992528	terbinafine hydrochloride 10 MG/ML Topical Cream	SCD	2
992528	terbinafine hydrochloride 1 % Topical Cream	SY	2

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
TERBINAFINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
55a24767-1759-5f6a-8888-ea4aa0adac21	Product name	1	20140508
db9701af-cb4f-b8ba-d282-6bc5b6b7c467	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0363-2083-01	2025-07-29	C162847	48780-1	3b156c62-2a56-fb37-e063-e6dba90a4e07	Terbinafine Hydrochloride

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0363-2083-01	Terbinafine Hydrochloride	15 g in 1 TUBE	CREAM	15		2
0363-2083-01	Terbinafine Hydrochloride	1 in 1 CARTON	CREAM	1		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0363-2083	TERBINAFINE HYDROCHLORIDE CREAM [WALGREEN COMPANY]	2	Legacy NDC, 2 package rows	20170718_d985c2a4-c0e8-4d87-9fcd-2b1aeda0198e.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Terbinafine Hydrochloride	ACTIVE INGREDIENT	012C11ZU6G	1
Terbinafine	ACTIVE MOIETY	G7RIW8S0XP	1
benzyl alcohol	INACTIVE INGREDIENT	LKG8494WBH	1
cetyl alcohol	INACTIVE INGREDIENT	936JST6JCN	1
cetyl palmitate	INACTIVE INGREDIENT	5ZA2S6B08X	1
isopropyl myristate	INACTIVE INGREDIENT	0RE8K4LNJS	1
polysorbate 60	INACTIVE INGREDIENT	CAL22UVI4M	1
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	1
sorbitan monostearate	INACTIVE INGREDIENT	NVZ4I0H58X	1
stearyl alcohol	INACTIVE INGREDIENT	2KR89I4H1Y	1
water	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Terbinafine Hydrochloride
Terbinafine
benzyl alcohol
cetyl alcohol
cetyl palmitate
isopropyl myristate
polysorbate 60
water
sodium hydroxide
sorbitan monostearate
stearyl alcohol

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0363-2083	0363-2083-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Terbinafine Hydrochloride	012C11ZU6G	ACTIB
benzyl alcohol	LKG8494WBH	IACT
cetyl alcohol	936JST6JCN	IACT
cetyl palmitate	5ZA2S6B08X	IACT
isopropyl myristate	0RE8K4LNJS	IACT
polysorbate 60	CAL22UVI4M	IACT
water	059QF0KO0R	IACT
sodium hydroxide	55X04QC32I	IACT
sorbitan monostearate	NVZ4I0H58X	IACT
stearyl alcohol	2KR89I4H1Y	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 302 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	LIQUID / ORAL	2 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	INJECTION / SUBCUTANEOUS		90 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	144 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAPLEURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
cetyl alcohol	CETYL ALCOHOL	936JST6JCN	SOLUTION / TOPICAL	NA		Exact identifier — unii candidate 20 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR	0.35 %w/v		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / URETERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sorbitan monostearate	SORBITAN MONOSTEARATE	NVZ4I0H58X	LOTION / TOPICAL		89 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	SUPPOSITORY / RECTAL	129 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	CREAM / TOPICAL	0.32 %w/w		Exact identifier — unii candidate 4 equally ranked IID candidates
stearyl alcohol	STEARYL ALCOHOL	2KR89I4H1Y	TABLET / ORAL		20 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
sorbitan monostearate	SORBITAN MONOSTEARATE	NVZ4I0H58X	SOLUTION / TOPICAL	NA		Exact identifier — unii candidate 11 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRA-ARTERIAL	176 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
sorbitan monostearate	SORBITAN MONOSTEARATE	NVZ4I0H58X	SUSPENSION / ORAL	62.5 mg/5ml		Exact identifier — unii candidate 11 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
stearyl alcohol	STEARYL ALCOHOL	2KR89I4H1Y	LOTION / TOPICAL		1140 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION/ DROPS / OPHTHALMIC	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SPONGE / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAMUSCULAR		78 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
cetyl alcohol	CETYL ALCOHOL	936JST6JCN	CREAM / TOPICAL		1280 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRACARDIAC	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
cetyl alcohol	CETYL ALCOHOL	936JST6JCN	TABLET, FILM COATED / ORAL	NA		Exact identifier — unii candidate 20 equally ranked IID candidates
polysorbate 60	POLYSORBATE 60	CAL22UVI4M	TABLET, COATED / ORAL	NA		Exact identifier — unii candidate 13 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / SUBMUCOSAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	EMULSION / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
cetyl alcohol	CETYL ALCOHOL	936JST6JCN	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	59 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	MOUTHWASH / BUCCAL	2 mg/1ml		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / ORAL		9120 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAVENOUS		456 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	OINTMENT / TOPICAL	2.2 %w/w		Exact identifier — unii candidate 50 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SOLUTION / SUBCUTANEOUS	0.95 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRASPINAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	CAPSULE / ORAL		450 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / INTRAMUSCULAR		40 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
isopropyl myristate	ISOPROPYL MYRISTATE	0RE8K4LNJS	CREAM / VAGINAL		50 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	TABLET, DELAYED RELEASE / ORAL	2.31 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRACAVITARY	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / RECTAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / RESPIRATORY (INHALATION)	8 %w/v		Exact identifier — unii candidate 174 equally ranked IID candidates
polysorbate 60	POLYSORBATE 60	CAL22UVI4M	EMULSION / ORAL	20 mg/1ml		Exact identifier — unii candidate 13 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	FILM, SOLUBLE / BUCCAL		5 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRA-ARTICULAR	1 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRAMUSCULAR		1000 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRADERMAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAVENOUS		78 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / INTRAVENOUS		242 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
isopropyl myristate	ISOPROPYL MYRISTATE	0RE8K4LNJS	OINTMENT / TOPICAL	35 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / URETHRAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR	5.4 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	POWDER / RESPIRATORY (INHALATION)	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
isopropyl myristate	ISOPROPYL MYRISTATE	0RE8K4LNJS	AEROSOL, SPRAY / TOPICAL	6.89 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
cetyl alcohol	CETYL ALCOHOL	936JST6JCN	SUSPENSION / TOPICAL	2.01 %w/w		Exact identifier — unii candidate 20 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRACAVITARY	0.01 ml		Exact identifier — unii candidate 50 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION/ DROPS / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077511-001	TERBINAFINE HYDROCHLORIDE	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL			2007-07-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
aab4fe7d-4fa1-4751-b681-3d041dc116ce			d985c2a4-c0e8-4d87-9fcd-2b1aeda0198e	2017-07-17	Warnings	Exact identifier spl id: aab4fe7d-4fa1-4751-b681-3d041dc116ce spl set id: d985c2a4-c0e8-4d87-9fcd-2b1aeda0198e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.